Gender specific association of ABCA1 gene R219K variant in coronary disease risk through interactions with serum triglyceride elevation in Turkish adults

Anadolu Kardiyoloji Dergisi

Volumn 14, Issue 1, 2014, Pages 18-25

  Çoban, Neslihan ^a   Onat, Altan ^b   Kömürcü Bayrak, Evrim ^a   Güleç, Çaǧri ^a   Can, Günay ^b   Erginel Ünaltuna, Nihan ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

ABCA1 gene variants; Coronary heart disease risk; Gender difference; Phospholipids; Regression analysis; Serum triglycerides; Turkish population

Indexed keywords

ABC TRANSPORTER A1; ABCA1 PROTEIN, HUMAN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; BLOOD; CAUCASIAN; CORONARY ARTERY DISEASE; FEMALE; GENDER IDENTITY; GENETIC PREDISPOSITION; GENETICS; HUMAN; MALE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEX DIFFERENCE; STATISTICAL MODEL; TURKEY;

ADULT; ATP BINDING CASSETTE TRANSPORTER 1; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENDER IDENTITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; TURKEY;

EID: 84894532137     PISSN: None     EISSN: 13080032     Source Type: Journal    
DOI: 10.5152/akd.2013.234     Document Type: Article

References (39)

1. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli W P, Knoke JD, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation 1989; 79: 8-15.
2. Fielding CJ, Fielding PE. Molecular physiology of reverse cholesterol transport. J Lipid Res 1995; 36: 211-228.
3. Hill SA, McQueen MJ. Reverse cholesterol transport-a review of the process and its clinical implications. Clin Biochem 1997; 30: 517-525.
4. Oram J F. HDL apolipoproteins and ABCA1: partners in the removal of excess cellular cholesterol. Arterioscler Thromb Vasc Biol 2003; 23: 720-727.
5. Yancey PG, Bortnick AE, Kellner-Weibel G, dela Llera-Moya M, Phillips MC, Rothblat GH. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol 2003; 23: 712-719.
6. Tall AR. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Intern Med 2008; 263: 256-273.
7. Singaraja RR, Brunham LR, Visscher H, Kastelein JJ, Hayden MR. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler Thromb Vasc Biol 2003; 23: 1322-1332.
8. Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 2004; 305: 869-872.
9. Porchay I, Pean F, Bellili N, Royer B, Cogneau J, Chesnier MC, et al. ABCA1 single nucleotide polymorphisms on high-density lipoprotein-cholesterol and overweight: the D.E.S.I.R. study. Obesity (Silver Spring) 2006; 14: 1874-1879.
10. Hodoǧlugil U, Williamson DW, Huang Y, Mahley RW. Common polymorphisms of ATP binding cassette transporter A1, including a functional promoter polymorphism, associated with plasma high- density lipoprotein cholesterol levels in Turks. Atherosclerosis 2005; 183: 199-212.
11. Clee SM, Zwinderman AH, Engert JC, Zwarts KY, Molhuizen HO, Roomp K, et al. Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease. Circulation 2001; 103: 1198-205.
12. Ma XY, Liu J P, Song ZY. Associations of the ATP-binding cassette transporter A1 R219K polymorphism with HDL-C level and coronary artery disease risk: a meta-analysis. Atherosclerosis 2011; 215: 428-434.
13. Pasdar A, Yadegarfar G, Cumming A, Whalley L, St Clair D, MacLeod MJ. The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile. BMC Med Genet 2007; 6: 8-30.
14. Brousseau ME, Bodzioch M, Schaefer EJ, Goldkamp AL, Kielar D, Probst M, et al. Common variants in the gene encoding ATP-binding cassette transporter 1 in men with low HDL cholesterol levels and coronary heart disease. Atherosclerosis 2001; 154: 607-611.
15. Li Y, Tang K, Zhou K, Wei Z, Zeng Z, He L, et al. Quantitative assessment of the effect of ABCA1 R219K polymorphism on the risk of coronary heart disease. Mol Biol Rep 2012; 39: 1809-1813.
16. Onat A, Hergenç G. On the criteria of metabolic syndrome in predicting incident coronary disease and diabetes in Turkish adults/abdominal obesity and cardiometabolic risk. Anadolu Kardiyol Derg 2007; 7: 212-213.
17. Onat A, Can G, Hergenç G, Küçükdurmaz Z, Uǧur M, Yüksel H. High absolute coronary disease risk among Turks: involvement of risk factors additional to conventional ones. Cardiology 2010; 115: 297-306.
18. Onat A, Can G, Kaya H, Hergenç G. "Atherogenic index of plasma" (log10 triglyceride/ high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes and vascular events. J Clin Lipidol 2010; 4: 89-98.
19. Onat A, Can G, Çiçek G, Ayhan E, Doǧan Y, Kaya H. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes and coronary disease in non-diabetic adults. Acta Diabetol 2011 Jul 16. Epub ahead of print.
20. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1-10.
21. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
22. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001; 285: 2486-2497.
23. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, National Heart, Lung and Blood Institute; American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
24. Onat A, Uyarel H, Hergenç G, Karabulut A, Albayrak S, Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 2007; 191: 182-190.
25. Rose GA, Blackburn H, Gillum R F, Prineas RJ. Cardiovascular Survey Methods, 2nd ed. Geneva, WHO; 1982.
26. Onat A, Can G, Ayhan E, Kaya Z, Hergenç G. Impaired protection against diabetes and coronary heart disease by high-density lipoproteins in Turks. Metabolism 2009; 58: 1393-1399.
27. Frikke-Schmidt R, Nordestgaard BG, Jensen GB, Steffensen R, Tybjaerg-Hansen A. Genetic variation in ABCA1 predicts ischemic heart disease in the general population. Arterioscler Thromb Vasc Biol 2008; 28: 180-186.
28. Abellán R, Mansego ML, Martínez-Hervás S, Martín-Escudero JC, Carmena R, Real JT, et al. Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study. Atherosclerosis 2010; 211: 203-209.
29. Kolovou V, Kolovou G, Marvaki A, Karakosta A, Vasilopoulos G, Kalogiani A, et al. ATP-binding cassette transporter A1 gene polymorphisms and serum lipid levels in young Greek nurses. Lipids Health Dis 2011; 13: 10-56.
30. Hergenç G, Onat A, Sariİ, Yazici M, Eryonucu B, Can G. Serum total and high-density lipoprotein phospholipid levels in a population-based study and relationship to risk of metabolic syndrome and coronary disease. Angiology 2008; 59: 26-35.
31. Lohner S, Fekete K, Marosvölgyi T, Decsi T. Gender differences in the long-chain polyunsaturated fatty acid status: systematic review of 51 publications. Ann Nutr Metab 2013; 62: 98-112.
32. Li J, Wang L F, Li ZQ, Pan W. Effect of R219K polymorphism of the ABCA1 gene on the lipid-lowering effect of pravastatin in Chinese patients with coronary heart disease. Clin Exp Pharmacol Physiol 2009; 36: 567-570.
33. Harada T, Imai Y, Nojiri T, Morita H, Hayashi D, Maemura K, et al. A common Ile 823 Met variant of ATP-binding cassette transporter A1 gene (ABCA1) alters high density lipoprotein cholesterol level in Japanese population. Atherosclerosis 2003; 169: 105-112.
34. Kitjaroentham A, Hananantachai H, Tungtrongchitr A, Pooudong S, Tungtrongchitr R. R219K polymorphism of ATP binding cassette transporter A1 related with low HDL in overweight/obese Thai males. Arch Med Res 2007; 38: 834-838.
35. Villard E F, EI Khoury P, Frisdal E, Bruckert E, Clement K, Bonnefont-Rousselot D, et al. Genetic determination of plasma cholesterol efflux capacity is gender-specific and independent of HDL-cholesterol levels. Arterioscler Thromb Vasc Biol 2013; 33: 822-828.
36. Jiang Z, Zhou R, Xu C, Feng G, Zhou Y. Genetic variation of the ATP-binding cassette transporter A1 and susceptibility to coronary heart disease. Mol Genet Metab 2011; 103: 81-88.
37. Navab M, Reddy ST, Van Lenten BJ, Buga GM, Hough G, Wagner AC, et al. High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: Novel hypotheses and review of literature. Arterioscler Thromb Vasc Biol 2012; 32: 2553-2560.
38. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, et al. Gut flora metabolism of posphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63.
39. St-Pierre J, Lemieux I, Perron B, Brisson D, Santuré M, Vohl MC, et al. Relation of the "hypertriglyceridemic waist" phenotype to earlier manifestations of coronary artery disease in patients with glucose intolerance and type 2 diabetes mellitus. Am J Cardiol 2007; 99: 3693-73.